Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2026 08:00 ET | Source: Provectus Biopharmaceuticals Inc.

Provectus Biopharmaceuticals Highlights Preclinical Evidence of PV-10-Mediated Immune Modulation in Burn Wound Healing; Porcine Study Demonstrates Shift Toward Pro-Regenerative Tissue Environment

KNOXVILLE, Tenn., April 02, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today highlighted newly published independent preclinical...
February 20, 2023 09:15 ET | Source: CMI

Negative Pressure Wound Therapy (NPWT) Devices Market to Surpass US$ 3,789.9 Million by 2030, Says Coherent Market Insights (CMI)

Burlingame, Feb. 20, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global negative pressure wound therapy (NPWT) devices market is estimated to be valued at US$ 2,288.1 million...
August 16, 2022 09:40 ET | Source: CMI

Global Negative Pressure Wound Therapy (NPWT) Devices Market to Surpass US$ 4,318.7 Million by 2030, Says Coherent Market Insights (CMI)

Seattle, Aug. 16, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global negative pressure wound therapy (NPWT) devices market is estimated to be valued at US$ 2,560.2 million in...
October 14, 2021 08:30 ET | Source: RenovaCare, Inc.

RenovaCare Establishes Leadership Position in Cell Isolation and Spray Technology with Newly Awarded U.S. Patent

SCOTTSDALE, Ariz., Oct. 14, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented cell therapy technologies for the regeneration of skin and tissues,...